Existing evidence supports the notion that TGF-β governs the dormant characteristics of both normal stem cells and disseminated tumor cells through the molecular pathway involving TGF-β2 signaling activation of MAPK p38α/β. This evidence concerns the gene TGFB1 and neoplasm.